B Desoize

2.4k total citations
58 papers, 1.9k citations indexed

About

B Desoize is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, B Desoize has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 20 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in B Desoize's work include Cancer therapeutics and mechanisms (11 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Cancer Treatment and Pharmacology (8 papers). B Desoize is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Cancer Treatment and Pharmacology (8 papers). B Desoize collaborates with scholars based in France, Ivory Coast and United States. B Desoize's co-authors include Claudie Madoulet, Philippe Collery, Bernhard K. Keppler, Gabriel G. Nahas, Jean‐Claude Jardillier, A Morishima, Jacques Robert, Annette K. Larsen, Jean‐François Riou and Claude-Louis Léger and has published in prestigious journals such as Science, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

B Desoize

58 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Desoize France	19	834	640	322	275	162	58	1.9k
Manon Carré France	27	675 0.8×	1.1k 1.7×	349 1.1×	180 0.7×	92 0.6×	65	2.3k
Akio Hoshi Japan	24	861 1.0×	1.0k 1.6×	373 1.2×	92 0.3×	76 0.5×	231	2.4k
Maurizio Viale Italy	25	634 0.8×	607 0.9×	693 2.2×	126 0.5×	116 0.7×	116	2.1k
Bastiaan Nuijen Netherlands	30	829 1.0×	1.0k 1.6×	215 0.7×	187 0.7×	184 1.1×	122	2.7k
Maja Osmak Croatia	24	740 0.9×	1.2k 1.8×	376 1.2×	83 0.3×	95 0.6×	115	2.4k
Yasuo Hata Japan	27	356 0.4×	1.3k 2.0×	303 0.9×	205 0.7×	449 2.8×	97	2.8k
Hyunseung Lee South Korea	31	372 0.4×	1.1k 1.7×	431 1.3×	404 1.5×	165 1.0×	107	2.5k
Elena Monti Italy	35	1.2k 1.4×	1.1k 1.7×	538 1.7×	325 1.2×	522 3.2×	119	3.5k
Ga Young Park South Korea	19	589 0.7×	650 1.0×	279 0.9×	197 0.7×	206 1.3×	45	1.6k
Ulrich Beyer Switzerland	27	533 0.6×	672 1.1×	196 0.6×	260 0.9×	124 0.8×	49	2.4k

Countries citing papers authored by B Desoize

Since Specialization

Citations

This map shows the geographic impact of B Desoize's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Desoize with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Desoize more than expected).

Fields of papers citing papers by B Desoize

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Desoize. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Desoize. The network helps show where B Desoize may publish in the future.

Co-authorship network of co-authors of B Desoize

This figure shows the co-authorship network connecting the top 25 collaborators of B Desoize. A scholar is included among the top collaborators of B Desoize based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Desoize. B Desoize is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Desoize, B & Claudie Madoulet. (2002). Particular aspects of platinum compounds used at present in cancer treatment. Critical Reviews in Oncology/Hematology. 42(3). 317–325. 318 indexed citations

Desoize, B. (2000). Multicellular resistance: a paradigm for clinical resistance?. Critical Reviews in Oncology/Hematology. 36(2-3). 193–207. 334 indexed citations

Desoize, B, et al.. (1999). Puzzles in the clinical pharmacokinetics of fluorouracil.. PubMed. 18(6B). 4607–10. 6 indexed citations

Desoize, B, et al.. (1998). La résistance multicellulaire : un autre mécanisme de résistance pléiotropique?. Bulletin du Cancer. 85(9). 785–793. 8 indexed citations

Bobichon, Hélène, et al.. (1998). Cofactors in In Vitro Induction of Apoptosis in HL60 Cells by All-trans Retinoic Acid (ATRA). Biochemical Pharmacology. 55(2). 177–184. 14 indexed citations

Desoize, B, et al.. (1996). Evaluation of a prediction model of cisplatin dose based on total platinum plasma concentration. European Journal of Cancer. 32(10). 1734–1738. 18 indexed citations

Desoize, B & Jacques Robert. (1994). Individual dose adaptation of anticancer drugs. European Journal of Cancer. 30(6). 844–851. 38 indexed citations

Larsen, Annette K., et al.. (1993). The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II. Biochemical Pharmacology. 46(8). 1403–1412. 99 indexed citations

Desoize, B. (1993). [To which criterion should the dosage of anticancer drug be adapted?].. PubMed. 80(5). 376–90. 2 indexed citations

10.

Desoize, B, et al.. (1992). Reduced Oral Etoposide Bioavailability in Patients With Advanced Cancer of the Head and Neck. JNCI Journal of the National Cancer Institute. 84(5). 348–351. 8 indexed citations

11.

Desoize, B, et al.. (1992). Evaluation of a method for detection of cells with reduced drug retention in solid tumours. Cytometry. 13(6). 630–637. 3 indexed citations

12.

Desoize, B, et al.. (1991). Comparison of Phosphatase Isoenzymes PAP and PSA with Bone Scan in Patients with Prostate Carcinoma. Clinical Nuclear Medicine. 16(9). 643–648. 22 indexed citations

13.

Desoize, B, et al.. (1991). Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma. Clinical Biochemistry. 24(5). 443–446. 21 indexed citations

14.

Desoize, B, et al.. (1991). Correlation of clinical pharmacokinetic parameters of cisplatin with efficacy and toxicity. Biomedicine & Pharmacotherapy. 45(4-5). 203–207. 19 indexed citations

15.

Desoize, B, et al.. (1990). Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumours. British Journal of Cancer. 62(5). 840–841. 20 indexed citations

16.

Desoize, B, et al.. (1990). Alterations of growth fraction and DNA content in K562 cells by differentiating agents. Cytometry. 11(8). 888–893. 2 indexed citations

17.

Desoize, B & Edward R. Garrett. (1989). Superiority of perfusion over bolus administration in cancer chemotherapy: Proposition of a compartmental model. Medical Hypotheses. 29(1). 21–24. 4 indexed citations

18.

Desoize, B, et al.. (1988). Effect of fagaronine on cell cycle progression of human erythroleukemia K562 cells. Leukemia Research. 12(8). 667–672. 16 indexed citations

19.

Desoize, B, et al.. (1987). Growth inhibition and morphological alteration of L 1210 cells by polyglutaraldehyde nanospheres.. PubMed. 19(4). 561–6. 2 indexed citations

20.

Kouamouo, Jonas, et al.. (1987). [Cytotoxic effects of root extracts of Fagara zanthoxyloides Lam. (Rutaceae) on the human erythroleukemia K 562 cell line].. PubMed. 45(1). 79–86. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact